STOCK TITAN

PACS (NYSE: PACS) investor plans sale of 10,296 common shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A Form 144 notice for PACS reports that Mark Hancock plans to sell 10,296 shares of PACS common stock through Citigroup Global Markets Inc. The planned sale has an aggregate market value of $463,680.36, with the shares listed on the NYSE and an approximate sale date of 07/14/2026. The notice also states that there are 15,827,237 shares of this class outstanding.

The common shares being sold were originally acquired on 03/01/2023 as part of the formation of the issuer, for cash. The Form 144 disclosure lists multiple PACS common stock sales by Mark Hancock over the prior three months, including transactions such as 153,254 shares sold on 06/15/2026 and 142,163 shares sold on 07/06/2026 for multi‑million dollar proceeds.

Positive

  • None.

Negative

  • None.
Shares proposed to be sold 10,296 shares Planned PACS common stock sale through Citigroup Global Markets Inc.
Aggregate market value of proposed sale $463,680.36 Value of 10,296 PACS common shares to be sold
Shares outstanding 15,827,237 shares Outstanding PACS common shares for the class referenced
Approximate sale date 07/14/2026 Approximate date of the proposed 10,296‑share sale
Prior sale on 06/15/2026 153,254 shares for $5,568,759.95 PACS common stock sale listed under Securities Sold During The Past 3 Months
Prior sale on 07/06/2026 142,163 shares for $6,444,860.09 Another large PACS sale by Mark Hancock in the past 3 months
Form 144 regulatory
"A Form 144 notice for PACS reports that Mark Hancock plans to sell"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
aggregate market value financial
"The planned sale has an aggregate market value of $463,680.36"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
securities to be sold regulatory
"144: Securities To Be Sold Common | 03/01/2023 | shares acquired"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months Mark Hancock 262 N."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the PACS Form 144 notice disclose?

The Form 144 notice discloses that Mark Hancock plans to sell 10,296 PACS common shares through Citigroup Global Markets Inc., with an aggregate market value of $463,680.36 and an approximate sale date of 07/14/2026 on the NYSE.

How many PACS shares are proposed to be sold by Mark Hancock?

Mark Hancock proposes to sell 10,296 shares of PACS common stock. The notice ties these shares to an aggregate market value of $463,680.36 and identifies Citigroup Global Markets Inc. as the broker handling the transaction.

When are the proposed PACS share sales expected to occur?

The proposed sale of PACS shares is expected around 07/14/2026. This date appears as the approximate sale date for the planned 10,296‑share transaction to be executed through Citigroup Global Markets Inc. on the NYSE.

How many PACS shares are outstanding according to the notice?

The notice states that there are 15,827,237 PACS common shares outstanding. This figure provides context for the planned 10,296‑share sale, indicating the size of the proposed disposition relative to the total class.

How were the PACS shares being sold by Mark Hancock originally acquired?

The PACS common shares were acquired on 03/01/2023 in a transaction described as "shares acquired at formation of the issuer", with the consideration identified as cash, indicating they were obtained during the issuer’s formation.

What prior PACS share sales by Mark Hancock are listed in the Form 144?

The notice lists multiple prior PACS sales over three months, including 153,254 shares sold for $5,568,759.95 on 06/15/2026 and 142,163 shares sold for $6,444,860.09 on 07/06/2026, along with several smaller transactions in June and July 2026.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature